Mylan Labs

Allergan heads to federal court to defend Restasis against early generic rivals
Fierce Pharma
Tue, 08/29/17 - 09:14 pm
Allergan
Restasis
generics
Mylan Labs
Teva Pharmaceutical
Akorn
InnoPharma
Mylan Can Focus on New Generics After EpiPen Medicaid Settlement
TheStreet.com
Tue, 08/22/17 - 12:08 am
Mylan Labs
generics
EpiPens
Medicaid
Mylan finalizes $465M settlement for EpiPen
BioPharma Dive
Thu, 08/17/17 - 11:50 pm
Mylan Labs
EpiPens
Opioid Makers Buffeted by Trump's Declaration of Addiction Crisis
TheStreet.com
Mon, 08/14/17 - 09:34 pm
opioids
opioid crisis
Donald Trump
Mylan Labs
Teva
INSYS Therapeutics
Sun's profit crushed as it pays $150M to settle Provigil pay-for-delay case
Fierce Pharma
Sun, 08/13/17 - 10:40 am
Sun Pharma
Provigil
pay-for-delay
generics
Mylan Labs
Mylan points finger at FDA for failure to win nods on Advair, Copaxone copies
Fierce Pharma
Fri, 08/11/17 - 10:55 am
Mylan Labs
FDA
Advair
Copaxone
generics
Teva Pharmaceutical
GSK
Feds pull Mylan, a small-time opioid drugmaker, into industrywide marketing probe
Fierce Pharma
Thu, 08/10/17 - 06:50 pm
Mylan Labs
opioids
SEC
DOJ
Mylan, like other generic drugmakers, feels the pricing pain
Stat
Wed, 08/9/17 - 03:10 pm
Mylan Labs
generics
drug pricing
Teva, Mylan Seen to Stay on M&A Sidelines
TheStreet.com
Sat, 08/5/17 - 10:08 pm
Teva Pharmaceutical
Mylan Labs
M&A
Express Scripts covers Mylan’s EpiPen on 2018 formulary, excluding rivals
Drug Delivery Business News
Tue, 08/1/17 - 11:11 am
Express Scripts
Mylan Labs
EpiPen
formulary
PBMs
The top 15 highest-paid biopharma executives
Fierce Pharma
Fri, 07/14/17 - 08:42 am
executive pay
Mylan Labs
Valeant Pharmaceuticals
Medivation
Regeneron
JNJ
Merck
The biosimilar pack is growing around Roche’s all-star trio, looking to rip into a $21B franchise
Endpoints
Wed, 07/12/17 - 10:36 am
Roche
biosimilars
Avastin
Herceptin
ABP 215
Amgen
MYL-14010
Mylan Labs
Rituxan
Biogen aims to block Tecfidera generics with flurry of lawsuits
Bizjournals.com
Tue, 07/4/17 - 11:22 pm
Biogen
Tecfidera
generics
MS
multiple sclerosis
Novartis
Sandoz
Mylan Labs
The EpiPen maker’s chairman earned more than $97 million last year — and investors aren’t happy
Washington Post, DC
Sun, 06/25/17 - 06:21 pm
Mylan Labs
EpiPens
executive pay
Robert Coury
Mylan offered EpiPen discounts to states in exchange for privileged status, documents show
Stat
Thu, 06/22/17 - 09:36 am
Mylan Labs
drug discounts
EpiPens
Mylan cut its tax rate into the single digits by investing in coal: Reuters
Fierce Pharma
Wed, 06/21/17 - 11:34 am
Mylan Labs
taxes
Mylan, embattled maker of EpiPen, faces a crucial test as angry investors plot to oust CEO
Stat
Wed, 06/21/17 - 09:43 am
Mylan Labs
EpiPens
investors
Heather Bresch
EpiPen alternative Symjepi gets FDA OK
BioPharma Dive
Fri, 06/16/17 - 09:46 pm
EpiPens
Mylan Labs
Symjepi
Adamis Pharmaceuticals
FDA
Investors are being told to go scorched earth on the company that makes EpiPen
Yahoo/Business Insider
Wed, 06/14/17 - 11:16 am
Mylan Labs
investors
EpiPens
Mylan agrees to meet with angry Sen. Grassley on EpiPen probe
Fierce Pharma
Sat, 06/3/17 - 09:19 am
Mylan Labs
Charles Grassley
drug pricing
EpiPens
Medicaid

Pages